Philips, Medtronic Seek To Navigate Lung Cancer Patients Toward Better Care
Executive Summary
The two medtech leaders announced a partnership to develop and commercialize the LungGPS patient management platform, originally developed by superDimension and acquired by Medtronic in the Coviden merger. The patient and data management platform helps track and manage patients diagnosed with lung nodules, from identifying the nodules on images, through diagnosis, treatment, and long-term survivorship.
You may also be interested in...
Medtronic And Philips Collaborate On Image-Guided Ablation For Atrial Fibrillation
Medtronic will co-promote Philips' Kodex-EPD dielectric imaging and navigation system with features to support atrial fibrillation ablation procedures.
Medtronic Launches Trial Of Covidien’s Lung Cancer Dx ‘Crown Jewel’
Medtronic has launched the NAVIGATE trial study to support and validate superDimension electromagnetic navigation system for obtaining lung tissue biopsies from the periphery of the lungs.
News We’re Watching: FDA Approves Medtronic's Affera, Roche's CGM Moves Closer To Approval, And More
Medtech Insight's News We're Watching covers medtech industry and research news you may have missed. This week, the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, included new results from studies of Roche's continuous glucose monitor and Medtronic's 780G insulin pump, Medtronic moved closer to earning FDA approval for its Affera ablation mapping and ablation system, and Linus Health expanded its technology for finding signs of cognitive problems in speech data.